ALX Oncology (ALXO) Short Interest Ratio & Short Volume $1.17 +0.14 (+13.59%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.16 -0.01 (-0.85%) As of 05:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALX Oncology Short Interest DataALX Oncology (ALXO) has a short interest of 4.48 million shares, representing 12.18% of the float (the number of shares available for trading by the public). This marks a 2.05% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.3, indicating that it would take 8.3 days of the average trading volume of 1.73 million shares to cover all short positions.Current Short Interest4,480,000 sharesPrevious Short Interest4,390,000 sharesChange Vs. Previous Month+2.05%Dollar Volume Sold Short$2.54 millionShort Interest Ratio8.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares53,550,000 sharesFloat Size36,790,000 sharesShort Percent of Float12.18%Today's Trading Volume2,863,698 sharesAverage Trading Volume1,731,174 sharesToday's Volume Vs. Average165% Short Selling ALX Oncology? Sign up to receive the latest short interest report for ALX Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALXO Short Interest Over TimeALXO Days to Cover Over TimeALXO Percentage of Float Shorted Over Time ALX Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20254,480,000 shares $2.54 million +2.1%12.2%8.3 $0.57 7/15/20254,390,000 shares $2.05 million -9.9%11.9%8.5 $0.47 6/30/20254,870,000 shares $2.02 million -10.5%14.4%9.2 $0.42 6/15/20255,440,000 shares $2.79 million -4.4%16.1%11.7 $0.51 5/31/20255,690,000 shares $2.76 million -2.4%16.8%10.9 $0.49 5/15/20255,830,000 shares $2.54 million -3.6%17.3%7.5 $0.44 4/30/20256,050,000 shares $3.27 million -1.5%17.8%7.6 $0.54 4/15/20256,140,000 shares $3.35 million -2.5%18.1%6.4 $0.55 3/31/20256,300,000 shares $3.92 million -1.4%18.5%6.2 $0.62 3/15/20256,390,000 shares $5.30 million +8.5%18.8%5.5 $0.83 Get the Latest News and Ratings for ALXO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/28/20255,890,000 shares $6.48 million -8.7%17.3%4.6 $1.10 2/15/20256,450,000 shares $7.10 million +7.7%19.2%6.1 $1.10 1/31/20255,990,000 shares $8.75 million -23.5%19.5%5.3 $1.46 1/15/20257,830,000 shares $12.76 million +3.0%25.4%6.9 $1.63 12/31/20247,600,000 shares $12.69 million -9.4%24.6%7.7 $1.67 12/15/20248,390,000 shares $12.17 million +17.0%24.4%9 $1.45 11/30/20247,170,000 shares $10.61 million -0.8%20.9%9.7 $1.48 11/15/20247,230,000 shares $9.33 million -7.8%21.1%10.6 $1.29 10/31/20247,840,000 shares $11.21 million -18.3%25.9%11.2 $1.43 10/15/20249,590,000 shares $14.96 million +2.9%31.7%8.8 $1.56 9/30/20249,320,000 shares $16.96 million -6.7%30.9%8.1 $1.82 9/15/20249,990,000 shares $22.18 million +0.1%33.1%8 $2.22 8/31/20249,980,000 shares $23.15 million +7.5%33.0%7.8 $2.32 8/15/20249,280,000 shares $24.59 million +2.2%31.0%6.7 $2.65 7/31/20249,080,000 shares $43.58 million +17.2%30.5%7.1 $4.80 7/15/20247,750,000 shares $62 million +40.7%26.0%9.1 $8.00 6/30/20245,510,000 shares $33.23 million +30.0%18.5%6.8 $6.03 6/15/20244,240,000 shares $34.13 million +45.7%14.2%5.8 $8.05 5/31/20242,910,000 shares $30.93 million -13.4%10.0%4.3 $10.63 5/15/20243,360,000 shares $50.47 million +6.3%11.6%6.2 $15.02 4/30/20243,160,000 shares $53.78 million -14.4%11.5%6.1 $17.02 4/15/20243,690,000 shares $47.56 million +18.3%13.5%8 $12.89 3/31/20243,120,000 shares $34.79 million +7.2%11.5%8 $11.15 3/15/20242,910,000 shares $32.88 million -16.4%10.7%7.7 $11.30 2/29/20243,480,000 shares $51.05 million -1.4%12.9%7.5 $14.67 2/15/20243,530,000 shares $59.27 million -2.5%13.1%7.8 $16.79 1/31/20243,620,000 shares $52.16 million -1.9%13.2%8 $14.41 1/15/20243,690,000 shares $52.91 million -2.1%13.5%8.2 $14.34 12/31/20233,770,000 shares $56.14 million -6.7%13.8%6.5 $14.89 12/15/20234,040,000 shares $54.74 million +3.1%14.8%2.9 $13.55Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.Click here to see the Tesla shock that could blindside everyone. 11/30/20233,920,000 shares $30.73 million +0.5%17.6%2.9 $7.84 11/15/20233,900,000 shares $34.20 million +2.1%17.5%3.1 $8.77 10/31/20233,820,000 shares $27.50 million -2.1%20.8%3.2 $7.20 10/15/20233,900,000 shares $35.61 million +46.1%21.2%3.3 $9.13 9/30/20232,670,000 shares $12.82 million -11.9%14.5%2.4 $4.80 9/15/20233,030,000 shares $15.70 million -4.1%16.5%19.1 $5.18 8/31/20233,160,000 shares $13.46 million +5.0%17.2%16.6 $4.26 8/15/20233,010,000 shares $14.63 million +2.0%16.5%14.9 $4.86 7/31/20232,950,000 shares $18.02 million +1.0%16.5%14.1 $6.11 7/15/20232,920,000 shares $19.77 million -0.3%16.2%11.2 $6.77 6/30/20232,930,000 shares $22.00 million No Change16.2%9.9 $7.51 6/15/20232,930,000 shares $28.01 million No Change16.2%9.9 $9.56 5/31/20232,930,000 shares $19.54 million +2.1%16.1%9.3 $6.67 5/15/20232,870,000 shares $18.54 million -4.3%16.3%9.8 $6.46 4/30/20233,000,000 shares $17.82 million -23.9%17.0%10.6 $5.94 4/15/20233,940,000 shares $18.91 million +3.4%22.3%15.4 $4.80 3/31/20233,810,000 shares $17.22 million -4.3%21.7%16.9 $4.52 3/15/20233,980,000 shares $20.66 million +3.7%22.6%17.2 $5.19 2/28/20233,840,000 shares $25.42 million +5.2%21.9%22.1 $6.62 2/15/20233,650,000 shares $28.32 million -5.7%20.8%22.2 $7.76 1/31/20233,870,000 shares $35.99 million -4.4%22.1%22.1 $9.30 1/15/20234,050,000 shares $40.54 million -2.4%23.1%22.8 $10.01 12/30/20224,150,000 shares $46.77 million +0.2%23.7%24.3 $11.27 12/15/20224,140,000 shares $43.72 million -3.0%23.6%29.1 $10.56 11/30/20224,270,000 shares $47.40 million No Change24.3%29.3 $11.10 11/15/20224,270,000 shares $49.53 million -1.8%24.3%26.3 $11.60 10/31/20224,350,000 shares $52.81 million -1.1%23.9%25.5 $12.14 10/15/20224,400,000 shares $48.36 million -3.5%24.1%23.9 $10.99 9/30/20224,560,000 shares $43.64 million No Change25.0%22.6 $9.57 9/15/20224,560,000 shares $57.64 million +6.5%25.0%18.6 $12.64 8/31/20224,280,000 shares $55.64 million +11.8%23.5%11.8 $13.00 8/15/20223,830,000 shares $57.99 million -5.9%21.0%9.4 $15.14 7/31/20224,070,000 shares $39.40 million +4.1%20.5%8.9 $9.68 7/15/20223,910,000 shares $40.51 million -3.5%19.7%8.3 $10.36 6/30/20224,050,000 shares $32.76 million -12.3%20.4%8.7 $8.09 6/15/20224,620,000 shares $30.82 million +5.0%23.2%9.6 $6.67 5/31/20224,400,000 shares $33.75 million +10.6%22.1%11.5 $7.67 5/15/20223,980,000 shares $38.45 million +8.2%20.0%10.6 $9.66 4/30/20223,680,000 shares $47.03 million -6.4%17.9%9.5 $12.78 4/15/20223,930,000 shares $62.92 million -10.9%19.2%8.7 $16.01 3/31/20224,410,000 shares $74.53 million +7.3%21.6%8.7 $16.90 3/15/20224,110,000 shares $68.23 million +3.8%20.1%8.2 $16.60 2/28/20223,960,000 shares $71.76 million -9.2%19.4%6.9 $18.12 2/15/20224,360,000 shares $68.41 million +10.9%21.4%7.4 $15.69 1/31/20223,930,000 shares $62.88 million -11.7%19.6%6.8 $16.00 1/15/20224,450,000 shares $82.33 million +0.9%22.1%9.1 $18.50 12/31/20214,410,000 shares $94.77 million +16.4%21.9%10.6 $21.49 12/15/20213,790,000 shares $93.84 million +11.8%18.8%9.8 $24.76 11/30/20213,390,000 shares $109.02 million +0.6%17.0%11.7 $32.16 11/15/20213,370,000 shares $156.33 million +59.0%16.9%13.6 $46.39Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.Click here to see the Tesla shock that could blindside everyone. 10/29/20212,120,000 shares $118.80 million -8.6%10.8%8.6 $56.04 10/15/20212,320,000 shares $136.86 million +1.3%11.8%9.1 $58.99 9/30/20212,290,000 shares $169.14 million -6.9%11.6%8.7 $73.86 9/15/20212,460,000 shares $192.35 million +2.5%12.5%8.5 $78.19 8/31/20212,400,000 shares $168 million -2.0%12.2%8.3 $70.00 8/13/20212,450,000 shares $163.32 million -6.1%12.5%8.9 $66.66 7/30/20212,610,000 shares $152.84 million +25.5%14.0%10.6 $58.56 7/15/20212,080,000 shares $109.22 million +1.5%11.0%9.8 $52.51 6/30/20212,050,000 shares $112.09 million +1.5%10.9%9.9 $54.68 6/15/20212,020,000 shares $116.78 million -6.5%10.7%11 $57.81 5/28/20212,160,000 shares $122.17 million -5.3%11.5%9.4 $56.56 5/14/20212,280,000 shares $119.91 million +2.7%12.1%9.3 $52.59 4/30/20212,220,000 shares $159.09 million -4.7%12.0%8.7 $71.66 4/15/20212,330,000 shares $139.33 million +2.2%12.6%9.2 $59.80 3/31/20212,280,000 shares $155.77 million +76.7%12.6%9.2 $68.32 3/15/20211,290,000 shares $99.52 million +30.3%7.1%5.1 $77.15 2/26/2021990,000 shares $81.84 million +27.5%5.5%4.3 $82.67 2/12/2021776,800 shares $62.87 million -19.2%4.3%3.6 $80.93 1/29/2021961,400 shares $74.64 million -17.1%5.3%4.8 $77.64 1/15/20211,160,000 shares $96.29 million No Change6.4%6.4 $83.01 ALXO Short Interest - Frequently Asked Questions What is ALX Oncology's current short interest? Short interest is the volume of ALX Oncology shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 4,480,000 shares of ALXO short. 12.18% of ALX Oncology's shares are currently sold short. Learn More on ALX Oncology's current short interest. What is a good short interest ratio for ALX Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALXO shares currently have a short interest ratio of 8.0. Learn More on ALX Oncology's short interest ratio. What is a good short interest percentage for ALX Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.18% of ALX Oncology's floating shares are currently sold short. Is ALX Oncology's short interest increasing or decreasing? ALX Oncology saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 4,480,000 shares, an increase of 2.1% from the previous total of 4,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ALX Oncology's float size? ALX Oncology currently has issued a total of 53,550,000 shares. Some of ALX Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ALX Oncology currently has a public float of 36,790,000 shares. How does ALX Oncology's short interest compare to its competitors? 12.18% of ALX Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ALX Oncology: Immuneering Corporation (6.04%), Genelux Corporation (6.37%), ALT5 Sigma Corporation (5.58%), Inhibikase Therapeutics, Inc. (4.58%), Compugen Ltd. (1.66%), Scilex Holding Company (8.76%), Fate Therapeutics, Inc. (8.57%), Protalix BioTherapeutics, Inc. (5.26%), Coherus Oncology, Inc. (30.35%), Avalo Therapeutics, Inc. (0.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short ALX Oncology stock? Short selling ALXO is an investing strategy that aims to generate trading profit from ALX Oncology as its price is falling. ALXO shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ALX Oncology? A short squeeze for ALX Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALXO, which in turn drives the price of the stock up even further. How often is ALX Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALXO, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies IMRX Short Interest GNLX Short Interest ALTS Short Interest IKT Short Interest CGEN Short Interest SCLX Short Interest FATE Short Interest PLX Short Interest CHRS Short Interest AVTX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALXO) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access